息：
https://www.hzndocs.com/KRYSTEXXA-Prescribing-Information.pdf
--------------------------------------------
KRYSTEXXA is not for use in people with too much uric acid in their bodies who do not have symptoms (asymptomatic hyperuricemia).
PRINCIPAL DISPLAY PANEL
NDC:75987-0080-10
KRYSTEXXA®
(pegloticase)
Injection
8 mg/mL
For Intravenous Infusion
Single-use vial. Discard unused portion
Must Be Diluted Prior To Administration
Dispense the enclosed Medication Guide to each patient
Rx Only
Lot #:
Exp:
C-490-11-US-C
Each 8 mg/mL vial of pegloticase contains:
8 mg uricase protein covalently linked to 24 mg PEG
Disodium hydrogen phosphate dihydrate...2.18 mg
Sodium chloride...8.77 mg
Sodium dihydrogen phosphate dihydrate...0.43 mg
Water for injection
See enclosed full prescribing information for dosage and administration.
No U.S. standard of potency.
Store in carton at 2°C-8°C (36°F-46°F).
Do not shake or freeze.
Protect from light. |
